Open AccessNovel Dosing Strategies Increase Exposures of the Potent Antituberculosis Drug Rifapentine but Are Poorly Tolerated in Healthy Volunteers
Author(s) -
Kelly E. Dooley,
Radojka M. Savic,
JeongGun Park,
Yoninah Cramer,
Richard Hafner,
Evelyn Hogg,
Jennifer Janik,
Mark A. Marzinke,
Kristine Y. Patterson,
Constance A. Benson,
Laura Hovind,
Susan E. Dorman,
David W. Haas
Publication year - 2015
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/48tz-4826
Subject(s) - rifapentine , dosing , medicine , pharmacology , drug , tuberculosis , mycobacterium tuberculosis , latent tuberculosis , pathology